Closed-end Fund IPOs
Dr. O'Neal describes a pattern of consistent losses relative to NAV observed after the IPO of closed end funds. Closed-end funds IPO at a 5% premium to their NAVs and within 6 months trade at a 5% discount to their NAVs. It appears that investing in a closed-end fund at the IPO is dominated by investments in seasoned mutual funds. This suggests that closed-end fund IPOs don't pass the NASD's 'reasonable basis' suitability test and recommendations to buy a closed-end fund at the IPO should therefore be per se unsuitable.